...
首页> 外文期刊>Molecular cancer research: MCR >Stromal cell-derived factor-1/chemokine (C-X-C motif) ligand 12 stimulates human hepatoma cell growth, migration, and invasion.
【24h】

Stromal cell-derived factor-1/chemokine (C-X-C motif) ligand 12 stimulates human hepatoma cell growth, migration, and invasion.

机译:基质细胞衍生因子-1 /趋化因子(C-X-C基序)配体12刺激人肝癌细胞的生长,迁移和侵袭。

获取原文
获取原文并翻译 | 示例

摘要

In addition to their physiologic effects in inflammation and angiogenesis, chemokines are involved in cancer pathology. The aim of this study was to determine whether the chemokine stromal cell-derived factor 1 (SDF-1) induces the growth, migration, and invasion of human hepatoma cells. We show that SDF-1 G protein-coupled receptor, chemokine (C-X-C motif) receptor 4 (CXCR4), and SDF-1 mRNA are expressed in human hepatoma Huh7 cells, which secrete and bind SDF-1. This binding depends on CXCR4 and glycosaminoglycans. SDF-1 associates with CXCR4, and syndecan-4 (SDC-4), a heparan sulfate proteoglycan at the plasma membrane of Huh7 cells, induces the growth of Huh7 cells by promoting their entry into the cell cycle, and inhibits the tumor necrosis factor-alpha-mediated apoptosis of the cells. SDF-1 also reorganizes Huh7 cytoskeleton and induces tyrosine phosphorylation of focal adhesion kinase. Finally, SDF-1 activates matrix metalloproteinase-9, resulting in increased migration and invasion of Huh7 cells. These biological effects of SDF-1 were strongly inhibited by the CXCR4 antagonist AMD3100, by a glycosaminoglycan, heparin, as well as by beta-D-xyloside treatment of the cells, or by c-jun NH(2)-terminal kinase/stress-activated protein kinase inhibitor. Therefore, the CXCR4, glycosaminoglycans, and the mitogen-activated protein kinase signaling pathways are involved in these events. The fact that reducing SDC-4 expression by RNA interference decreased SDF-1-induced Huh7 hepatoma cell migration and invasion strongly indicates that SDC-4 may be an auxiliary receptor for SDF-1. Finally, the fact that CXCR4 is expressed in hepatocellular carcinoma cells from liver biopsies indicates that the in vitro results reported here could be extended to in vivo conditions.
机译:除其在炎症和血管生成中的生理作用外,趋化因子还参与癌症病理学研究。这项研究的目的是确定趋化因子基质细胞衍生因子1(SDF-1)是否诱导人肝癌细胞的生长,迁移和侵袭。我们显示,SDF-1 G蛋白偶联受体,趋化因子(C-X-C模体)受体4(CXCR4)和SDF-1 mRNA在人类肝癌Huh7细胞中表达,该细胞分泌并结合SDF-1。这种结合取决于CXCR4和糖胺聚糖。 SDF-1与CXCR4和Syndecan-4(SDC-4)结合,它是Huh7细胞质膜上的硫酸乙酰肝素蛋白聚糖,通过促进Huh7细胞进入细胞周期来诱导其生长,并抑制肿瘤坏死因子-α介导的细胞凋亡。 SDF-1还重组Huh7细胞骨架,并诱导粘着斑激酶的酪氨酸磷酸化。最后,SDF-1激活基质金属蛋白酶9,导致Huh7细胞迁移和侵袭增加。 SDF-1的这些生物学效应受到CXCR4拮抗剂AMD3100,糖胺聚糖,肝素以及细胞的β-D-木糖苷处理或c-jun NH(2)-末端激酶/应激的强烈抑制活化的蛋白激酶抑制剂。因此,CXCR4,糖胺聚糖和有丝分裂原激活的蛋白激酶信号转导通路都参与这些事件。通过RNA干扰降低SDC-4表达可降低SDF-1诱导的Huh7肝癌细胞迁移和侵袭的事实,强烈表明SDC-4可能是SDF-1的辅助受体。最后,CXCR4在肝活检的肝细胞癌细胞中表达的事实表明此处报道的体外结果可以扩展到体内条件。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号